retatrutide triple hormone receptor agonist benefits The power of three: Retatrutide's role in modern obesity and diabetes therapy Retatrutide—A Game Changer in Obesity

A recent review, published by the Journal of the Endocrine Society has concluded that these medications, traditionally prescribed for glycemic control and weight management are emerging as a promising treatment for a variety of additions

How Much Weight Loss Has Retatrutide Shown In Clinical Trials

Many adults, especially after forty, face changes in metabolism, hormones, and body composition that make weight loss much harder than it used to be

October 5, 2023

Dulaglutide and cardiovascular outcomes in type 2 diabetes (Rewind): a double-blind, randomised placebo-controlled trial

Efficacy and safety of once-weekly semaglutide versus once-daily Sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (sustain 2): a 56-week, double-blind, phase 3a, randomised trial